First antigen kit by Indian Company ‘Pathocatch Covid-19’

Date:

Share post:

Pathocatch Covid-19 Antigen Rapid testing kit, a test kit, is developed and manufactured in India. It can be ordered immediately as it is made available. The testing kit will be priced around Rs 450.

The Indian Council of Medical Research (ICMR) on Wednesday officially agreed the second rapid antigen kit to treat the corona virus. It has been developed by Mylab Discovery Solutions which is a Biotechnology company that develops and sells molecular diagnostic detection kits, to enable labs to obtain trustworthy, timely, and actionable answers, and is the first test kit made in India, which has been accepted.

The name of this test kit is ‘Pathocache covid-19 Antigen Rapid Testing Kit’. It is a made in India kit and will be available in the market. The price of the kit is Rs. 450/-.

Managing Director of ‘MyLab Discovery Solutions’ Hasmukh Rawal said that the team of MyLab is performing everything possible to fight and eradicate. Lowering the rate of RT-PCR test kit which get ICMR approval for use in India now we don’t have to depend on foreign kits.

He also informed  that after getting conformation for antigen testing kit, they will be try to cover the entire spectrum of covid-19. They tried out every possible way to fight with this situation as soon as possible.

Antigen-based testing is being used to strengthen the country’s overall testing capacity and treat patients, along with RRT-PCR. Rapid antigen test several benefit than RT-PCR. Rapid antigen test takes less time only 30 minutes and also laboratory is not required. On other hand RRT-PCR testing takes 5hours and also required laboratory.

Jacob John, former head of the department of virology at Christian Medical College, Vellore, said there is only one way to prevent the rate of infection. People those are susceptible should be tested as fast as possible and isolate them so that they cannot further spread it.

Earlier, ICMR had approved an antigen test kit prepared by SD Biosensor, a South Korean company. A branch of this company is located in Manesar, Haryana.

ALSO READ: India races to release first indigenous Covid-19 vaccine by August 15

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Newsletter Signup

Related articles from Tags

Omicron is spreading fast, crossed 200 mark in India: MoHFW reports

Maharashtra and Delhi have reported to reached the highest number of 54 cases of COVID's new variant,...

CBSE announces Special Board Exams for Classes 10 and 12

The Central Board of Secondary Education (CBSE) announced that it will conduct special board exams for classes...

Rise in COVID cases in Chittoor District of Andhra Pradesh

Wile the whole country is just recovering from the shadows of the second wave, the threat of...

Rich People are leaving India for Better Investment says GWM Review

Yes, more and more rich Indians are leaving India for better Investment and opportunities. According to the...

How Dangerous is the Delta Variant?

The fear of the latest Delta Plus variant is coming true. It has spread to about a...

How long can your vaccine protect you from COVID-19

The coronavirus pandemic has hit mankind drastically. Apparently, it has left its scars behind for next 100...

Covid-19 Pandemic has the Positive side too, here is the proof

Covid-19 Pandemic has brought things from better to worse for some. Most of them lost their loved...

COVID-19 Third Wave to Hit India by October: Experts

Around 40 medical experts from around the world participated in a survey by Reuters, the famous media...

COVID Vaccine Gap: AlJazeera Versus NDTV

The government of India extended the COVID vaccine gap between the two doses of the Covishield vaccine...

Kumbh Mela: 1 L Fake COVID-19 Reports issued, Single Phone Number Used For 50 People

In a recent development, The Haridwar district administration ordered an investigation. It alleged that fake COVID-19 test...

Novavax Vaccine: COVID-19 Shot About 90% Effective -Study

American biotechnology company and vaccine maker Novavax said that its vaccine is about 90 per cent effective...

Panic Over Dose Interval of Covishield Vaccine Not Needed -Centre

Media is continuously reporting about the interval between the doses of Covishield vaccine. But, Dr. V.K. Paul...